AN ACT TO AMEND SECTION 41-29-137, MISSISSIPPI CODE OF 1972, TO REQUIRE THE PRESCRIBER OF A SCHEDULE II CONTROLLED SUBSTANCE OR ANY OTHER OPIOID DRUG, BEFORE ISSUING THE INITIAL PRESCRIPTION IN A COURSE OF TREATMENT FOR ACUTE OR CHRONIC PAIN AND AGAIN BEFORE ISSUING THE THIRD PRESCRIPTION OF THE COURSE OF TREATMENT, TO DISCUSS WITH THE PATIENT THE RISKS ASSOCIATED WITH THE DRUG BEING PRESCRIBED AND ALTERNATIVE TREATMENTS THAT MAY BE AVAILABLE; AND FOR RELATED PURPOSES.
Impact
The introduction of HB 956 is expected to reinforce accountability among medical practitioners when prescribing opioid medications. By requiring physicians to have these critical discussions with their patients, the bill seeks to enhance patient safety and encourage alternative pain management strategies. This legislative change aligns with the broader efforts to combat prescription drug abuse and addiction, thus potentially reducing the long-term impact of opioid dependency within the state.
Summary
House Bill 956 aims to amend Section 41-29-137 of the Mississippi Code of 1972, addressing the prescription guidelines for Schedule II controlled substances and opioids. The bill mandates that prescribers discuss the risks associated with these drugs, including the potential for addiction and overdose, and available alternative treatments with patients prior to issuing the initial prescription and again before the third prescription in a treatment course. This measure is seen as a response to the ongoing opioid crisis, highlighting the importance of informed patient consent and awareness regarding the dangers of opioid use.
Contention
Notably, while the bill has garnered support for its proactive approach to patient safety and education, it may also face opposition. Concerns may arise over the implementation of these requirements, particularly regarding the additional burden on healthcare providers and the potential impact on patient access to necessary pain relief. Critics could argue that such mandates, while well-intentioned, might complicate the prescribing process and inadvertently lead to patients not receiving appropriate care, as practitioners could become overly cautious in their prescribing habits.
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.
Medical marijuana licenses; establishing certain requirements for license issuance; allowing certain actions by certain licensees; requiring certain information to be documented in certain inventory manifest prior to certain action. Effective date.